ArticleJournal of hepatocellular carcinoma2024

Hepatic Arterial Infusion Chemotherapy Combined Lenvatinib and PD-1 Inhibitor Showed Improved Survival for Infiltrative Hepatocellular Carcinoma: A Multicenter Cohort Study.

Ruixia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.